Greater PhiladelphiaFunding Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations May 5, 2026
Greater PhiladelphiaEvents Why Global Health Startups Are Entering the U.S. More Prepared Than Ever May 4, 2026
Greater PhiladelphiaPeople The Hidden Variable in Advanced Therapies: You Can’t Control Everything April 29, 2026
Greater PhiladelphiaPeople When Quality Control Scales, Discipline Is the First Thing at Risk April 27, 2026
Greater PhiladelphiaIndustry Trends Minaris Hits 100% Batch Success on Chimeric’s CDH17 CAR-T Program as Autologous Manufacturing Enters a More Disciplined Era April 23, 2026
Greater PhiladelphiaEvents From Bench to Backing: Inside BioLabs Investor Day at the Curtis April 22, 2026
Greater PhiladelphiaIndustry Trends Three Philly-Area Startups Accelerating Breakthroughs and Milestones with Lean Commercialization Approach April 22, 2026
Greater PhiladelphiaFunding Greater Philadelphia-based Aprea Therapeutics Raises $30M to Extend Runway and Reposition Its Precision Oncology Bet April 21, 2026
Greater PhiladelphiaEvents Behind Every Therapy: How Analytical Sciences Can Impact Speed and Success April 21, 2026
Greater PhiladelphiaFunding Pinnacle Medicines’ $89M Raise Signals a New Bet on Oral Peptides—and a Different Kind of Biotech Build April 20, 2026
Greater PhiladelphiaEvents National Conference for Bioscience Financial Officers is Coming to Philadelphia – “One More Round” April 20, 2026
Career & Professional DevelopmentCareer Tips Rethinking the Research Model: Why Real-World Complexity Must Shape the Future of Preclinical Science April 17, 2026
Career & Professional DevelopmentCareer Tips Cracking the Clinical Research Job Market: Why Strategy, Not Volume, Wins in Today’s Hiring Landscape April 15, 2026
How Structured Data and AI Are Reshaping Antibody Development and Tomorrow’s Therapeutics April 8, 2026
5 Questions With Angela Fernandez Iglesias, founder of Ciencia con Acento, and Editorial and Insights Contributor Ambassador for BioBuzz April 7, 2026
